Skip to content
DraconiticResearch
Search Sources API
197,768 studies31 sourcesUpdated 22 min ago
PreprintCC BY-NDmedRxiv

Molecular epidemiology of respiratory syncytial virus infections in Arizona, USA during the 2023-24 and 2024-25 seasons.

5 more authors
  1. 1Arizona State University

Abstract

Respiratory syncytial virus infection is a common cause of hospitalizations in infants and elderly patients. With the increased availability of vaccines and therapeutic antibodies, surveilling the sequence landscape of viral genomes is important to increase awareness of potentially neutralizing mutations. During the 2023-24 and 2024-25 RSV seasons, we collected unpaired nasopharyngeal swab specimens from patients presenting to Arizona healthcare systems with symptoms of influenza-like illness. Using either tiled amplicon-based enrichment or a commercial oligo hybrid-enrichment panel and next generation sequencing, we obtained genome sequences for RSV and co-infecting viruses. We performed phylogenetic and genomic analyses to classify RSV genomes and detect mutations in the antigenic sites of the F protein and conserved central domain of the G protein. Phylogenetic analysis showed RSV-A strains belonged to the A.D. 1, A.D.2, A.D.3, and A.D. 5 subclades. RSV-B genomes belonged to the B.D.4.1, B.D.4.1.1, B.D.E.1, B.D.E.5, and B.D.E. 7 clades. We found 9 polymorphic sites located in the antigenic sites of the F protein in our RSV-A genomes and 18 polymorphic sites in our RSV-B genomes over the two-season surveillance period. We identified 7 polymorphic sites in our RSV-A genomes and 8 polymorphic sites in our RSV-B genomes that are in the conserved central domain of the G protein. We also discovered 3 (6.7%) and 27 (15.8%) incidences of viral coinfections in the 2023-24 and 2024-25 seasons, respectively. Viral genomic surveillance plays an important role in maintaining the efficacy of vaccine and therapeutic agents. Continued monitoring of circulating variants is an important component of public health.

Related

  1. Epidemiology and seasonality of respiratory syncytial virus among hospitalized pediatric patients with lower respiratory tract infections in Negeri Sembilan, Malaysia (2017–2024)
    Nuur Hafizah Md Iderus, Sarbhan Singh, David Chun-Ern Ng +12
    Frontiers in Public HealthPeer-reviewedCC BY 4.0Full textEpidemiology & public healthCrossrefDOAJ
  2. Respiratory pathogen epidemiology in children under 5 years hospitalized with acute respiratory infections in Qingdao, China: a retrospective, single-center, repeated cross-sectional surveillance study
    Translational pediatricsPeer-reviewedCC BY-NC-NDFull textGeneral medicineEurope PMC
  3. Nosocomial Respiratory Syncytial Virus in the Post-Pandemic Era: Evolving Epidemiology and Integrated Prevention Strategies.
    Po-Hsiu Huang, Pei-Hsuan Huang, Po-Yu Liu +1
    Healthcare (Basel, Switzerland)Peer-reviewedCC BYFull textEpidemiology & public healthEurope PMC
  4. Respiratory Syncytial Virus infections in immunosuppressed adults <65 years old: a comparative analysis with Influenza and SARS-CoV2
    M. Danysz, E. Barnes, S. H. Lim +3
    medRxivPreprintCC BYFull textInfectious diseasemedRxiv
  5. Cardiac Complications of Infections Due to Respiratory Syncytial Virus and Human Metapneumovirus: A Systematic Review and Pooled Analysis of Clinical Features.
    Matteo Riccò, Luca Pipitò, Claudio Costantino +5
    VirusesPeer-reviewedCC BYFull textEpidemiology & public healthEurope PMC
BibTeX
@misc{holland2026molecular,
  title = {{Molecular epidemiology of respiratory syncytial virus infections in Arizona, USA during the 2023-24 and 2024-25 seasons.}},
  author = {S. C. Holland and L. A. Holland and T. Porter and V. Boyle and N. Ramasamy and M. White and R. Salgado and M. Desulme and L. Nordstrom and M. Patel and J. Estrada and J. Kramer and E. S. Lim and N. Woodbury and S. White and D. Engelthaler and V. Murugan},
  howpublished = {medRxiv},
  year = {2026},
  month = sep,
  doi = {10.64898/2026.09.09.26362646},
  url = {https://www.medrxiv.org/content/10.64898/2026.09.09.26362646v1},
  note = {CC BY-ND},
}
RIS
TY  - UNPB
TI  - Molecular epidemiology of respiratory syncytial virus infections in Arizona, USA during the 2023-24 and 2024-25 seasons.
AU  - S. C. Holland
AU  - L. A. Holland
AU  - T. Porter
AU  - V. Boyle
AU  - N. Ramasamy
AU  - M. White
AU  - R. Salgado
AU  - M. Desulme
AU  - L. Nordstrom
AU  - M. Patel
AU  - J. Estrada
AU  - J. Kramer
AU  - E. S. Lim
AU  - N. Woodbury
AU  - S. White
AU  - D. Engelthaler
AU  - V. Murugan
PY  - 2026
DA  - 2026/09/09
PB  - medRxiv
DO  - 10.64898/2026.09.09.26362646
UR  - https://www.medrxiv.org/content/10.64898/2026.09.09.26362646v1
AB  - Respiratory syncytial virus infection is a common cause of hospitalizations in infants and elderly patients. With the increased availability of vaccines and therapeutic antibodies, surveilling the sequence landscape of viral genomes is important to increase awareness of potentially neutralizing mutations. During the 2023-24 and 2024-25 RSV seasons, we collected unpaired nasopharyngeal swab specimens from patients presenting to Arizona healthcare systems with symptoms of influenza-like illness. Using either tiled amplicon-based enrichment or a commercial oligo hybrid-enrichment panel and next generation sequencing, we obtained genome sequences for RSV and co-infecting viruses. We performed phylogenetic and genomic analyses to classify RSV genomes and detect mutations in the antigenic sites of the F protein and conserved central domain of the G protein. Phylogenetic analysis showed RSV-A strains belonged to the A.D. 1, A.D.2, A.D.3, and A.D. 5 subclades. RSV-B genomes belonged to the B.D.4.1, B.D.4.1.1, B.D.E.1, B.D.E.5, and B.D.E. 7 clades. We found 9 polymorphic sites located in the antigenic sites of the F protein in our RSV-A genomes and 18 polymorphic sites in our RSV-B genomes over the two-season surveillance period. We identified 7 polymorphic sites in our RSV-A genomes and 8 polymorphic sites in our RSV-B genomes that are in the conserved central domain of the G protein. We also discovered 3 (6.7%) and 27 (15.8%) incidences of viral coinfections in the 2023-24 and 2024-25 seasons, respectively. Viral genomic surveillance plays an important role in maintaining the efficacy of vaccine and therapeutic agents. Continued monitoring of circulating variants is an important component of public health.
ER  -